UK and European Research at a Glance

This report provides a curated summary of RBC Capital Markets' recent research on Ag chemicals, biopharma, energy commodities, and specific company updates across the UK and Europe.

Key Takeaways

• 1.Biopharma funding has surged significantly, with YTD funding up ~141% Y/Y.
• 2.The macro environment remains supportive for BP p.l.c. despite ongoing boardroom drama chatter.
• 3.Ag fundamentals are improving due to rising direct-to-farm payments, despite yield forecast adjustments.

Table of Contents

• Premium Research
• Company Comments
• Industry Comments
• Quick Takes
• Global Commodity Strategy and MENA
• Disclaimer